Black Cohosh as used to treat Menopause

What are Remifemin Ingredients?

Black Cohosh (Cimicifugae racemosae rhizoma)


The Active Ingredient in Remifemin that makes it a perfect menopause support product is Black Cohosh (Cimicifugae racemosae rhizoma). Black Cohosh has a long tradition as a medical plant used to treat numerous different indications, and has had a multitude of clinical research and studies performed on it. Some of the most relevant studies can be found in the studies/articles section of our website.

Remifemin contains a high potency, standardises extract of the Black Cohosh plant. The patented extract was first used in 1956 to produce the very first Remifemin in Germany. Very soon after the release of Remifemin a plethora of clinical studies and research data became available proving the efficacy and tolerability of the product.

Remifemin is the most studied form of black cohosh, with more than 20 clinical trials and open scientific monitoring trials in physicians’ practices. Remifemin has a Grade of Recommendation A – which represents a seal of approval which is rarely achieved by herbal medicinal products and offers a profound basis for qualified counselling of menopausal patients.

The standardised black cohosh extract in Remifemin is:

  • Backed by 50 years of clinical studies.
  • Proven to be effective, safe, and well tolerated.
  • Obstetrician and gynecologist recommended.
  • Clinically proven to reduce hot flushes, night sweats, related sleeplessness,
    irritability, and mood swings associated with menopause.

In modern times many Black Cohosh containing products have been developed, but none using the superior and unique extraction process that sets Remifemin apart from the rest. Most Black Cohosh products have been and gone, while Remifemin stands strong as the trusted Menopause Support product for thousands of women around the world.

Pack of Remifemin 120 Tablets
NZ Remifemin Pack

Remifemin is Free of gluten, yeast, preservatives and artificial colours

1 Comment

  1. Zeynep
    March 29, 2018



Leave a Reply

Your email address will not be published.

Scroll to top